Related Experiment Videos
Recombinant human interleukin 5 is a selective activator of human eosinophil function
A F Lopez1, C J Sanderson, J R Gamble
1Division of Human Immunology, Institute of Medical and Veterinary Science, Adelaide, South Australia.
The Journal of Experimental Medicine
|January 1, 1988
Summary
Human recombinant interleukin-5 (rIL-5) selectively stimulates human eosinophils, impacting their structure and function. This suggests rIL-5 plays a key role in eosinophilia and activation observed in various diseases.
Area of Science:
- Immunology
- Cell Biology
Background:
- Eosinophils are key immune cells involved in allergic responses and parasite defense.
- The specific molecular triggers for eosinophil activation and accumulation in disease remain an area of active research.
Purpose of the Study:
- To investigate the selective effects of human recombinant interleukin-5 (rIL-5) on human eosinophils.
- To determine if rIL-5 can induce functional and morphological changes in eosinophils.
Main Methods:
- Incubation of human eosinophils with purified human rIL-5.
- Microscopic analysis to assess morphological changes.
- Functional assays to evaluate eosinophil activity.
Main Results:
- Human rIL-5 demonstrated selective stimulation of human eosinophils.
- Significant morphological alterations were observed in eosinophils treated with rIL-5.
- rIL-5 enhanced the functional capacity of human eosinophils.
Conclusions:
- Human rIL-5 is a potent activator of human eosinophils.
- The findings identify rIL-5 as a critical factor in eosinophilia and eosinophil activation in disease states.